Are you refractory to some of the existing myeloma medications? Are you a relapsed patient? Myeloma experts Drs. John Burke, Faith Davies and Noopur Raje along with patient advocate, Jack Aiello, gathered at the 2015 American Society of Hematology (ASH) meeting for a discussion covering subjects of maintenance treatment until progression to deepen response and achieve MRD negativity, creative uses of combination therapy, and specific clinical trials, all aimed to improve relapsed and refractory patients quality and quantity of life.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo